"Bridge the gap and accelerate India's advancements in innovative therapies"

Dr Ramesh Mundlamuri has over 19 years of experience in various biopharmaceutical organizations and has ample experience in various divisions and sections of the biopharmaceutical industry, including Research & Development, Technology Transfer, Commercial Manufacturing, Product & Process Development, Operations Management and so on.

Prior to joining Duoning, he worked at Biological E in Hyderabad, India. In his role as Assistant General Manager, he led the commercial manufacturing of polysaccharide conjugate and protein-based Vaccines. Before that, he worked for Panacea Biotech, Sartorius, Sanofi and Krebs Biochemical Industries.

Dr Ramesh Mundlamuri is well-versed in cGMP, GLP, GDP and various regulatory bodies (WHO, EU, ROW, FDA, NRA). He also possesses extensive experience in the management of several vaccines, including polysaccharide vaccines, recombinant viral proteins, conventional vaccines and carrier protein.

Attributed to the BioE3 (Biotechnology for Economy, Employment and Environment) Policy, India's bioeconomy has seen exponential growth, ballooning from $10 billion in 2014 to a staggering $130 billion in 2024, with expectations to reach $300 billion by 2030. This policy also emphasizes the strategic objective of transitioning from chemical-based industries to sustainable bio-based models, promoting a circular bioeconomy. In this context, India has attracted numerous international biopharmaceutical companies to engage in business, which have absorbed a large number of local talents to better meet the demands of the domestic market. Dr Ramesh Mundlamuri joined Duoning Biotech (a comprehensive bioprocessing solutions provider) as the Head of Technology in 2023. In a discussion, he talked about the opportunities available in the Indian market and shared his insights and experiences in conducting bioprocessing business within the country.

We notice that most of Duoning's product offerings are centered around biomanufacturing, which may require customization or extensive testing. How do you provide support to local customers quickly and efficiently?